Literature DB >> 18647114

Molecular engineering of viral gene delivery vehicles.

David V Schaffer1, James T Koerber, Kwang-il Lim.   

Abstract

Viruses can be engineered to efficiently deliver exogenous genes, but their natural gene delivery properties often fail to meet human therapeutic needs. Therefore, engineering viral vectors with new properties, including enhanced targeting abilities and resistance to immune responses, is a growing area of research. This review discusses protein engineering approaches to generate viral vectors with novel gene delivery capabilities. Rational design of viral vectors has yielded successful advances in vitro, and to an extent in vivo. However, there is often insufficient knowledge of viral structure-function relationships to reengineer existing functions or create new capabilities, such as virus-cell interactions, whose molecular basis is distributed throughout the primary sequence of the viral proteins. Therefore, high-throughput library and directed evolution methods offer alternative approaches to engineer viral vectors with desired properties. Parallel and integrated efforts in rational and library-based design promise to aid the translation of engineered viral vectors toward the clinic.

Entities:  

Mesh:

Year:  2008        PMID: 18647114      PMCID: PMC2683887          DOI: 10.1146/annurev.bioeng.10.061807.160514

Source DB:  PubMed          Journal:  Annu Rev Biomed Eng        ISSN: 1523-9829            Impact factor:   9.590


  159 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.

Authors:  N V Somia; M Zoppé; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

3.  Rapid evolution of a protein in vitro by DNA shuffling.

Authors:  W P Stemmer
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

4.  Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.

Authors:  N Kasahara; A M Dozy; Y W Kan
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

5.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

6.  Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity.

Authors:  H Neda; C H Wu; G Y Wu
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

7.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

Authors:  J C Burns; T Friedmann; W Driever; M Burrascano; J K Yee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

Authors:  T R Flotte; S A Afione; C Conrad; S A McGrath; R Solow; H Oka; P L Zeitlin; W B Guggino; B J Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

Review 9.  Adenovirus-mediated in vivo gene transfer.

Authors:  S L Brody; R G Crystal
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

10.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  47 in total

1.  Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Authors:  Hyunjung Baek; Hiroaki Uchida; Kyungok Jun; Jae-Hong Kim; Masahide Kuroki; Justus B Cohen; Joseph C Glorioso; Heechung Kwon
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  Cationic glycopolymers for the delivery of pDNA to human dermal fibroblasts and rat mesenchymal stem cells.

Authors:  Karina Kizjakina; Joshua M Bryson; Giovanna Grandinetti; Theresa M Reineke
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

3.  Comparison of transfection efficiency of nonviral gene transfer reagents.

Authors:  Seiichi Yamano; Jisen Dai; Amr M Moursi
Journal:  Mol Biotechnol       Date:  2010-11       Impact factor: 2.695

4.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 5.  Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons.

Authors:  Corentin Claeys Bouuaert; Ronald M Chalmers
Journal:  Genetica       Date:  2009-08-02       Impact factor: 1.082

6.  Gateway to the diseased brain.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Nat Med       Date:  2009-10       Impact factor: 53.440

Review 7.  Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.

Authors:  Devan L Puhl; Anthony R D'Amato; Ryan J Gilbert
Journal:  Brain Res Bull       Date:  2019-06-05       Impact factor: 4.077

Review 8.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

9.  Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

Authors:  Michael J Castle; Heikki T Turunen; Luk H Vandenberghe; John H Wolfe
Journal:  Methods Mol Biol       Date:  2016

Review 10.  Synthetic biology: tools to design, build, and optimize cellular processes.

Authors:  Eric Young; Hal Alper
Journal:  J Biomed Biotechnol       Date:  2010-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.